[1] 宋昊,马建东,陈永新,等.奥氮平联合牛黄宁宫片治疗难治性精神分裂症[J].中国实验方剂学杂志,2013,19(21):306-310. [2] Solanki R K, Singh P, Munshi D. Current perspectives in the treatment of resistant schizophrenia[J]. Indian J Psychiatry, 2009, 51(4):254-260. [3] 朱倩芸,皮峻峰.帕利哌酮缓释片与奥氮平治疗难治性精神分裂症的对照研究[J].中国新药杂志,2012,21(6):666-669. [4] Zhong K X, Sweitzer D E, Hamer R M, et a1. Comparison of quetiapine and risperidone in the treatment of schizophrenia:a randomized,double-blind,flexible-dose,8-week Study[J]. J Clin Psych-iatry, 2006, 67(7):1093-1103. [5] 杨永和,刘冬梅,徐进.大黄合并无抽搐电休克治疗精神分裂症的疗效与安全性分析[J].中国实验方剂学杂志,2013,19(24):335-337. [6] 蒲城城,姚贵忠,任峰,等.难治性精神分裂症患者的临床特点[J].中国心理卫生杂志,2012,26(8):566-570. [7] 马传青,顿志平.立体定向双侧多靶点射频毁损治疗难治性精神分裂症[J].山东大学学报,2011,49(11):111-113. [8] Larmo I, D E Nayer A, Windhager E, et a1. Efficacy and tolerability of quetiapine in patients with schizophrenia who switched from haloperidol,olanzapine or risperidone[J].Hum Psychopharmacol, 2005, 20(8):573-581. [9] 袁刚,曾昱,余雪芹.奎硫平与利培酮治疗73例首发精神分裂症的对照研究[J].重庆医学,2014,43(4):411-414. [10] Altamura A C, Sassella F, Santini A, et a1. Intramuscular preparations of antipsychotics:uses and relevance in clinical practice[J]. Drugs, 2003, 63(5):493-512. [11] Francey S M , Nelson B, Thompson A, et a1.Who needs antipsychotic medication in the earliest stages of psychosis? A reconsid-eration of benefits,risks,neurology and ethics in the era of early intervention[J]. Schizophr Res, 2010, 119(13):1-10. [12] EeantiS V, Mogg A J, Pluck G C, et a1. Methohexitone,propofol and etomidate in electr0c0nvulsive therapy for depression:a naturalistic comparison study[J]. J Affect Disord, 2009, 113(1-2):165-71. [13] 章龙泽,陈阳.无抽搐电休克对精神分裂症患者工作记忆的影响[J].中华行为医学与脑科学杂志,2013,22(12):1089-1091. |